Experimental DS HR B-ALL (SER) | Patients receive induction, consolidation, interim maintenance, delayed intensification, interim maintenance and maintenance therapies.
See outline for details. | Drug: Cyclophosphamide Given IV Other names: - (-)-Cyclophosphamide
- 2H-1,3,2-Oxazaphosphorine, 2-[bis(2-chloroethyl)amino]tetrahydro-, 2-oxide, monohydrate
- Carloxan
- Ciclofosfamida
- Ciclofosfamide
- Cicloxal
- Clafen <
Drug: DexamethasonePO or IV Other names: - Aacidexam
- Adexone
- Aknichthol Dexa
- Alba-Dex
- Alin
- Alin Depot
- Alin Oftalmico
- Amplidermis
- Anemul mono
- Auricularum
- Auxiloson
- Baycadron
- Baycut
Other: Laboratory Biomarker AnalysisCorrelative studies Drug: MercaptopurineGiven PO Other names: |
Experimental Group I Arm B (HR B-ALL) (CLOSED 03/19/2018) | Patients receive induction, consolidation, interim maintenance, delayed intensification and maintenance therapies.
See outline for details. | Drug: Cyclophosphamide Given IV Other names: - (-)-Cyclophosphamide
- 2H-1,3,2-Oxazaphosphorine, 2-[bis(2-chloroethyl)amino]tetrahydro-, 2-oxide, monohydrate
- Carloxan
- Ciclofosfamida
- Ciclofosfamide
- Cicloxal
- Clafen <
Drug: DexamethasonePO or IV Other names: - Aacidexam
- Adexone
- Aknichthol Dexa
- Alba-Dex
- Alin
- Alin Depot
- Alin Oftalmico
- Amplidermis
- Anemul mono
- Auricularum
- Auxiloson
- Baycadron
- Baycut
Other: Laboratory Biomarker AnalysisCorrelative studies Drug: MercaptopurineGiven PO Other names: |
Experimental Group II Arm B (VHR B-ALL - Exp Arm1) (CLOSED 02/15/2017) | Patients receive consolidation, interim maintenance, delayed intensification and maintenance therapies.
See outline for details. | Drug: Cyclophosphamide Given IV Other names: - (-)-Cyclophosphamide
- 2H-1,3,2-Oxazaphosphorine, 2-[bis(2-chloroethyl)amino]tetrahydro-, 2-oxide, monohydrate
- Carloxan
- Ciclofosfamida
- Ciclofosfamide
- Cicloxal
- Clafen <
Drug: EtoposideGiven IV Other names: - Demethyl Epipodophyllotoxin Ethylidine Glucoside
- EPEG
- Lastet
- Toposar
- Vepesid
- VP 16
- VP 16-213
- VP-16
- VP-16-213
- VP16
Other: Laboratory Biomarker AnalysisCorrelative studies Drug: MercaptopurineGiven PO Other names: |
Experimental Group III PH-like predicted TKI-sensitive kinase mutation | Patients receive induction, consolidation, interim maintenance, delayed intensification, interim maintenance and maintenance therapies.
See outline for details. | Drug: Cyclophosphamide Given IV Other names: - (-)-Cyclophosphamide
- 2H-1,3,2-Oxazaphosphorine, 2-[bis(2-chloroethyl)amino]tetrahydro-, 2-oxide, monohydrate
- Carloxan
- Ciclofosfamida
- Ciclofosfamide
- Cicloxal
- Clafen <
Drug: DasatinibGiven PO Other names: - BMS-354825
- Dasatinib Hydrate
- Dasatinib Monohydrate
- Sprycel
Drug: DexamethasonePO or IV Other names: - Aacidexam
- Adexone
- Aknichthol Dexa
- Alba-Dex
- Alin
- Alin Depot
- Alin Oftalmico
- Amplidermis
- Anemul mono
- Auricularum
- Auxiloson
- Baycadron
- Baycut
Other: Laboratory Biomarker AnalysisCorrelative studies Drug: MercaptopurineGiven PO Other names: - 3H-Purine-6-thiol
- 6 MP
- 6 Thiohypoxanthine
- 6 Thiopurine
- 6-Mercaptopurine
- 6-Mercaptopurine Monohydrate
- 6-MP
- 6-Purinethiol
- 6-Thiopurine
- 6-Thioxopurine
- Drug: Pegaspargase
Given IV Other names: - L-Asparaginase with Polyethylene Glycol
- Oncaspar
- Oncaspar-IV
- PEG-Asparaginase
- PEG-L-Asparaginase
- PEG-L-Asparaginase (Enzon - Kyowa Hakko)
- PEGLA
- Polyethylene Glyc
- Drug: Vincristine Sulfate
Given IV Other names: - Kyocristine
- Leurocristine Sulfate
- Leurocristine, sulfate
- Oncovin
- Vincasar
- Vincosid
- Vincrex
- Vincristine, sulfate
- Drug: Cytarabine
Given IT, IV, or SC Other names: - .beta.-Cytosine arabinoside
- 1-.beta.-D-Arabinofuranosyl-4-amino-2(1H)pyrimidinone
- 1-.beta.-D-Arabinofuranosylcytosine
- 1-Beta-D-arabinofuranosyl-4-amino-2(1H)pyrimidinone
- 1-Beta
- Drug: Daunorubicin Hydrochloride
Given IV Other names: - Cerubidin
- Cerubidine
- Cloridrato de Daunorubicina
- Daunoblastin
- Daunoblastina
- Daunoblastine
- Daunomycin Hydrochloride
- Daunomycin, hydrochloride
- Daunorubicin.HC
- Drug: Doxorubicin Hydrochloride
Given IV Other names: - 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy]-7,8, 9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, hydrochloride, (8S-cis)- (9CI)
- ADM
- Drug: Leucovorin Calcium
Given PO or IV Other names: - Adinepar
- Calcifolin
- Calcium (6S)-Folinate
- Calcium Folinate
- Calcium Leucovorin
- Calfolex
- Calinat
- Cehafolin
- Citofolin
- Citrec
- Citrovorum Factor
- C
- Drug: Methotrexate
Given IT and IV Other names: - Abitrexate
- Alpha-Methopterin
- Amethopterin
- Brimexate
- CL 14377
- CL-14377
- Emtexate
- Emthexat
- Emthexate
- Farmitrexat
- Fauldexato
- Folex
- Folex PFS
- Drug: Prednisone
Given PO or IV Other names: - .delta.1-Cortisone
- 1, 2-Dehydrocortisone
- Adasone
- Cortancyl
- Dacortin
- DeCortin
- Decortisyl
- Decorton
- Delta 1-Cortisone
- Delta-Dome
- Deltacortene
- De
|
Experimental DS HR B-ALL (RER) | Patients receive induction, consolidation, interim maintenance, delayed intensification, interim maintenance and maintenance therapies.
See outline for details. | Drug: Cyclophosphamide Given IV Other names: - (-)-Cyclophosphamide
- 2H-1,3,2-Oxazaphosphorine, 2-[bis(2-chloroethyl)amino]tetrahydro-, 2-oxide, monohydrate
- Carloxan
- Ciclofosfamida
- Ciclofosfamide
- Cicloxal
- Clafen <
Drug: DexamethasonePO or IV Other names: - Aacidexam
- Adexone
- Aknichthol Dexa
- Alba-Dex
- Alin
- Alin Depot
- Alin Oftalmico
- Amplidermis
- Anemul mono
- Auricularum
- Auxiloson
- Baycadron
- Baycut
Other: Laboratory Biomarker AnalysisCorrelative studies Drug: MercaptopurineGiven PO Other names: |
Experimental Group I Arm A (HR B-ALL) | Patients receive induction, consolidation, interim maintenance, delayed intensification and maintenance therapies.
See outline for details. | Drug: Cyclophosphamide Given IV Other names: - (-)-Cyclophosphamide
- 2H-1,3,2-Oxazaphosphorine, 2-[bis(2-chloroethyl)amino]tetrahydro-, 2-oxide, monohydrate
- Carloxan
- Ciclofosfamida
- Ciclofosfamide
- Cicloxal
- Clafen <
Drug: DexamethasonePO or IV Other names: - Aacidexam
- Adexone
- Aknichthol Dexa
- Alba-Dex
- Alin
- Alin Depot
- Alin Oftalmico
- Amplidermis
- Anemul mono
- Auricularum
- Auxiloson
- Baycadron
- Baycut
Other: Laboratory Biomarker AnalysisCorrelative studies Drug: MercaptopurineGiven PO Other names: |
Active Comparator Group II Arm A (VHR B-ALL - Control Arm) | Patients receive induction, consolidation, interim maintenance, delayed intensification and maintenance therapies.
See outline for details. | Drug: Cyclophosphamide Given IV Other names: - (-)-Cyclophosphamide
- 2H-1,3,2-Oxazaphosphorine, 2-[bis(2-chloroethyl)amino]tetrahydro-, 2-oxide, monohydrate
- Carloxan
- Ciclofosfamida
- Ciclofosfamide
- Cicloxal
- Clafen <
Drug: DexamethasonePO or IV Other names: - Aacidexam
- Adexone
- Aknichthol Dexa
- Alba-Dex
- Alin
- Alin Depot
- Alin Oftalmico
- Amplidermis
- Anemul mono
- Auricularum
- Auxiloson
- Baycadron
- Baycut
Other: Laboratory Biomarker AnalysisCorrelative studies Drug: MercaptopurineGiven PO Other names: |
Experimental Group II Arm C (VHR B-ALL - Exp Arm 2) (CLOSED 09/12/2014) | Patients receive induction, consolidation, interim maintenance, delayed intensification and maintenance therapies.
See outline for details. | Drug: Cyclophosphamide Given IV Other names: - (-)-Cyclophosphamide
- 2H-1,3,2-Oxazaphosphorine, 2-[bis(2-chloroethyl)amino]tetrahydro-, 2-oxide, monohydrate
- Carloxan
- Ciclofosfamida
- Ciclofosfamide
- Cicloxal
- Clafen <
Drug: DexamethasonePO or IV Other names: - Aacidexam
- Adexone
- Aknichthol Dexa
- Alba-Dex
- Alin
- Alin Depot
- Alin Oftalmico
- Amplidermis
- Anemul mono
- Auricularum
- Auxiloson
- Baycadron
- Baycut
Drug: EtoposideGiven IV Other names: - Demethyl Epipodophyllotoxin Ethylidine Glucoside
- EPEG
- Lastet
- Toposar
- Vepesid
- VP 16
- VP 16-213
- VP-16
- VP-16-213
- VP16
Other: Laboratory Biomarker AnalysisCorrelative studies Drug: MercaptopurineGiven PO Other names: |